Search research articles
Contact Us
Filters
Showing results (31-40 of 186) with videos related to
Page
of 19
Sort By:
The Netherlands Journal of Medicine
|
November 8, 2011
New insights into the pathogenesis of chronic myeloid leukaemia: towards a path to cure
N Thielen, G J Ossenkoppele, G-J Schuurhuis, et al.
Anti-Cancer Drugs
|
January 16, 1999
Costs of intensive treatment and follow-up of patients with multiple myeloma
I Buijt, G J Ossenkoppele, C A Uyl-de Groot, et al.
Journal of Hematotherapy & Stem Cell Research
|
January 25, 2000
Stem cell transplantations in patients with malignant lymphoma: costs in a Dutch university hospital in the period 1984-1995
C A Uyl-de Groot, G J Ossenkoppele, I Buijt, et al.
European Journal of Nuclear Medicine
|
December 1, 1993
Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography
O S Hoekstra, A van Lingen, G J Ossenkoppele, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
December 11, 1993
[Cell and disease. III. Apoptosis, the biological opposite of mitosis]
A A van de Loosdrecht, G J Ossenkoppele, R H Beelen, et al.
Haematologica
|
December 30, 2006
Mucormycosis in a patient with low risk myelodysplasia treated with anti-TNF-alpha
A Keijzer, P van der Valk, G J Ossenkoppele, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 3, 2014
Improved risk stratification by the integration of the revised international prognostic scoring system with the myelodysplastic syndromes comorbidity index
M F van Spronsen, G J Ossenkoppele, R Holman, et al.
Journal of Neuro-Oncology
|
January 1, 1993
Long-term effects of vincristine on the peripheral nervous system
T J Postma, B A Benard, P C Huijgens, et al.
Leukemia Research
|
January 1, 1991
Quantitative enzyme determination in acute myeloid leukemia
G J Ossenkoppele, P J Wijermans, P C Huijgens, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Low-dose cytarabine for acute myeloid leukaemia and myelodysplastic syndromes: in vivo and in vitro cytotoxicity
G J Ossenkoppele, P W Wijermans, J J Nauta, et al.
Page
of 19
Search research articles
Search
Showing results (31-40 of 186) with videos related to
Sort By:
Page
of 19
The Netherlands Journal of Medicine
|
November 8, 2011
New insights into the pathogenesis of chronic myeloid leukaemia: towards a path to cure
N Thielen, G J Ossenkoppele, G-J Schuurhuis, et al.
Anti-Cancer Drugs
|
January 16, 1999
Costs of intensive treatment and follow-up of patients with multiple myeloma
I Buijt, G J Ossenkoppele, C A Uyl-de Groot, et al.
Journal of Hematotherapy & Stem Cell Research
|
January 25, 2000
Stem cell transplantations in patients with malignant lymphoma: costs in a Dutch university hospital in the period 1984-1995
C A Uyl-de Groot, G J Ossenkoppele, I Buijt, et al.
European Journal of Nuclear Medicine
|
December 1, 1993
Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography
O S Hoekstra, A van Lingen, G J Ossenkoppele, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
December 11, 1993
[Cell and disease. III. Apoptosis, the biological opposite of mitosis]
A A van de Loosdrecht, G J Ossenkoppele, R H Beelen, et al.
Haematologica
|
December 30, 2006
Mucormycosis in a patient with low risk myelodysplasia treated with anti-TNF-alpha
A Keijzer, P van der Valk, G J Ossenkoppele, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 3, 2014
Improved risk stratification by the integration of the revised international prognostic scoring system with the myelodysplastic syndromes comorbidity index
M F van Spronsen, G J Ossenkoppele, R Holman, et al.
Journal of Neuro-Oncology
|
January 1, 1993
Long-term effects of vincristine on the peripheral nervous system
T J Postma, B A Benard, P C Huijgens, et al.
Leukemia Research
|
January 1, 1991
Quantitative enzyme determination in acute myeloid leukemia
G J Ossenkoppele, P J Wijermans, P C Huijgens, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Low-dose cytarabine for acute myeloid leukaemia and myelodysplastic syndromes: in vivo and in vitro cytotoxicity
G J Ossenkoppele, P W Wijermans, J J Nauta, et al.
Page
of 19